Package 60687-719-25

{"route": ["ORAL"], "spl_id": "3a390373-77eb-b7d8-e063-6294a90accfb", "openfda": {"nui": ["N0000175462", "M0015066", "N0000009947"], "unii": ["G70B4ETF4S", "OTT9J7900I"], "rxcui": ["476556"], "spl_set_id": ["c7fdb26d-d1e0-4f0f-b43b-2b7ee3b349c5"], "pharm_class_cs": ["Nucleosides [CS]"], "pharm_class_epc": ["Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"], "pharm_class_moa": ["Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "manufacturer_name": ["American Health Packaging"]}, "finished": true, "packaging": [{"sample": false, "description": "30 BLISTER PACK in 1 CARTON (60687-719-25)  / 1 TABLET, FILM COATED in 1 BLISTER PACK (60687-719-95)", "package_ndc": "60687-719-25", "marketing_end_date": "20260331", "marketing_start_date": "20231023"}], "brand_name": "Emtricitabine and tenofovir disoproxil fumarate", "product_id": "60687-719_3a390373-77eb-b7d8-e063-6294a90accfb", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]", "Nucleosides [CS]", "Nucleosides [CS]"], "product_ndc": "60687-719", "generic_name": "Emtricitabine and tenofovir disoproxil fumarate", "labeler_name": "American Health Packaging", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Emtricitabine and tenofovir disoproxil fumarate", "active_ingredients": [{"name": "EMTRICITABINE", "strength": "200 mg/1"}, {"name": "TENOFOVIR DISOPROXIL FUMARATE", "strength": "300 mg/1"}], "application_number": "ANDA212689", "marketing_category": "ANDA", "marketing_end_date": "20260331", "marketing_start_date": "20231023"}